Literature DB >> 21692945

Knowledge, attitudes and behaviours associated with the provision of hepatitis C care by Canadian family physicians.

J Cox1, L Graves, E Marks, C Tremblay, R Stephenson, A Lambert-Lanning, M Steben.   

Abstract

The role of primary care physicians in providing care for hepatitis C virus (HCV) infection is increasingly emphasized, but many gaps and challenges remain. This study explores family physicians' knowledge, attitudes and practices associated with providing care for HCV infection. Seven hundred and forty-nine members of the College of Family Physicians of Canada (CFPC) completed a self-administered survey examining knowledge, attitudes and behaviours regarding HCV infection screening and care. Multivariate analyses were performed using the outcome, HCV care provision, and variables based on a conceptual model of practice guideline adherence. Family physicians providing basic-advanced HCV care were more likely to be older, practice in a rural setting, have injection drug users (IDU) in their practice and have higher levels of knowledge about the initial assessment (OR = 1.77; 95% CI = 1.23-2.54) and treatment of HCV (OR = 1.74; 95% CI = 1.24-2.43). They were also less likely to believe that family physicians do not have a role in HCV care (OR = 0.41; 95% CI = 0.30-0.58). Educational programmes should target physicians less likely to provide HCV care, namely family physicians practicing in urban areas and those who do not care for any IDU patients. Training and continuing medical education programmes that aim to shift family physicians' attitudes about the provision of HCV care by promoting their roles as integral to HCV care could contribute to easing the burden on consultant physicians and lead to improved access to treatment for HCV infection.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21692945     DOI: 10.1111/j.1365-2893.2010.01426.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  11 in total

1.  Patterns of practice and barriers to care for hepatitis C in the direct-acting antiviral (DAA) era: A national survey of Canadian infectious diseases physicians.

Authors:  Justin Chan; Jim Young; Joseph Cox; Roy Nitulescu; Marina B Klein
Journal:  Can Liver J       Date:  2018-12-25

2.  Hepatitis and liver disease knowledge and preventive practices among health workers in Mexico: a cross-sectional study.

Authors:  Noreen Islam; Yvonne N Flores; Paula Ramirez; Roshan Bastani; Jorge Salmerón
Journal:  Int J Public Health       Date:  2013-10-06       Impact factor: 3.380

3.  Formal hepatitis C education enhances HCV care coordination, expedites HCV treatment and improves antiviral response.

Authors:  Samali Lubega; Uchenna Agbim; Miranda Surjadi; Megan Mahoney; Mandana Khalili
Journal:  Liver Int       Date:  2013-03-20       Impact factor: 5.828

4.  Variation between Canadian centres in the uptake of treatment for hepatitis C by patients coinfected with HIV: a prospective cohort study.

Authors:  Jim Young; Martin Potter; Joseph Cox; Curtis Cooper; John Gill; Mark Hull; Sharon Walmsley; Marina B Klein
Journal:  CMAJ Open       Date:  2013-09-24

5.  Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France).

Authors:  Dominique Salmon-Ceron; Julien Cohen; Maria Winnock; Perrine Roux; Firouze Bani Sadr; Eric Rosenthal; Isabelle Poizot Martin; Marc-Arthur Loko; Marion Mora; Philippe Sogni; Bruno Spire; François Dabis; Maria Patrizia Carrieri
Journal:  BMC Health Serv Res       Date:  2012-03-12       Impact factor: 2.655

6.  What affects response rates in primary healthcare-based programmes? An analysis of individual and unit-related factors associated with increased odds of non-response based on HCV screening in the general population in Poland.

Authors:  Natalia Parda; Małgorzata Stępień; Karolina Zakrzewska; Kazimierz Madaliński; Agnieszka Kołakowska; Paulina Godzik; Magdalena Rosińska
Journal:  BMJ Open       Date:  2016-12-07       Impact factor: 2.692

7.  Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C-SCOPE Study.

Authors:  Alain H Litwin; Martine Drolet; Chizoba Nwankwo; Martha Torrens; Andrej Kastelic; Stephan Walcher; Lorenzo Somaini; Emily Mulvihill; Jochen Ertl; Jason Grebely
Journal:  J Viral Hepat       Date:  2019-06-11       Impact factor: 3.728

8.  Evaluating the Effectiveness of the AIDS Education and Training Center (AETC) National Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Curriculum.

Authors:  Waridibo E Allison; Aro N Choi; Keito Kawasaki; Trisha V Melhado
Journal:  J Med Educ Curric Dev       Date:  2021-09-30

9.  Reasons for Nonattendance across the Hepatitis C Disease Course.

Authors:  Gail Butt; Liza McGuinness; Terri Buller-Taylor; Sandi Mitchell
Journal:  ISRN Nurs       Date:  2013-09-11

10.  Strengths and Weaknesses in the Risk Management of Blood-Borne Infections: Qualitative Research in Public Health.

Authors:  Anita Gębska Kuczerowska; Artur Błoński; Joanna Kuczerowska; Robert Gajda
Journal:  Int J Environ Res Public Health       Date:  2020-09-12       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.